7 KILLED, HUNDREDS INJURED AS STRONG QUAKE HITS SULAWESI, INDONESIA
VATICAN: POPE FRANCIS, FORMER POPE BENEDICT BOTH GET COVID-19 VACCINE
AUSTRALIA REBUKES GOOGLE FOR BLOCKING LOCAL CONTENT
JAPAN TO BAN ENTRY OF FOREIGN ATHLETES TO TRAIN AHEAD OF SUMMER OLYMPICS
BIDEN INAUGURATION WILL FEATURE DIVERSE PERFORMANCES INCLUDING LADY GAGA, JENNIFER LOPEZ
COURT ORDERS ARREST OF COPS ACCUSED OF KILLING ARMY MEN IN JOLO
THE PANDEMIC SLAMS PHL VEHICLE SALES IN 2020
CHESS PLAYER WESLEY SO BAGS P11.8M, JOINS WORLD’S TOP ESPORT EARNERS
ZSA ZSA PADILLA FINALLY VISITS THE GRAVE OF ‘COMEDY KING’ DOLPHY AGAIN
DUTERTE: PRESIDENCY JOB NOT FOR A WOMEN

ASTRAZENECA PUTS COVID-19 VACCINE TRIAL ON HOLD OVER SAFETY CONCERN

7 months ago | World Science & Technology News | 0 comments

By Xai Reyes

Health news website Stat News reported that AstraZeneca Plc had put a hold on the late-state trials of its highly -anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant.

In a statement, AstraZeneca spokesperson said the standard review process triggered a pause to vaccination to allow a review of safety data.

The study is testing a COVID-19 vaccine being developed by AstraZeneca and the University of Oxford researchers at sites, including the United States and the United Kingdom, where the adverse event was reported.

The nature of the safety issue and when it happened were not immediately known, although the participant is expected to recover.

The report said the suspension of the trial was having an impact on other AstraZeneca vaccine trials – as well as on clinical trials being conducted by other vaccine makers.

0 Comments

Submit a Comment

Your email address will not be published.

Social Media